PackGene Custom AAV Services: Advancing Gene Delivery Research with Quality, Flexibility, and Technical Expertise

Introduction

Adeno-associated virus, or AAV, has become one of the most important gene delivery platforms in biomedical research and gene therapy development. Because AAV vectors can deliver genetic material to a wide range of cells and tissues, they are widely used in neuroscience, ophthalmology, liver-directed research, muscle studies, immunology, disease modeling, and preclinical therapeutic development.

As AAV applications become more diverse and technically demanding, researchers often require customized vector solutions rather than standard catalog products. Custom AAV services allow investigators to select the most appropriate serotype, promoter, expression cassette, production scale, purification strategy, and quality control package for their specific research goals. PackGene provides integrated custom AAV services designed to support these needs, from vector design and plasmid construction to AAV production, purification, and analytical characterization.

AAV Production Services

High-Efficiency AAV Production Capabilities

Custom AAV production requires coordination across molecular biology, cell culture, vector packaging, purification, and quality testing. PackGene supports AAV projects through flexible production workflows that can accommodate different research applications, vector designs, and development stages.

A high-quality custom AAV service should help researchers address several key questions:

• Which AAV serotype or capsid is most suitable for the target tissue or cell type?
• Is the expression cassette compatible with AAV packaging capacity?
• Which promoter and regulatory elements are appropriate for the desired expression pattern?
• What production scale and purification method are needed for the experiment?
• What quality control assays are required for reliable downstream use?

PackGene’s AAV production service includes more than 70 serotype options, fast research-grade turnaround, scalable production options, and quality-focused analytical workflows. Its AAV production platform supports research-grade through GMP-oriented development needs, with listed capabilities including low empty capsids, high genome integrity, endotoxin control, and comprehensive analytical testing.

Quality Control and Product Characterization

AAV product quality directly affects experimental reproducibility, biological interpretation, and preclinical development decisions. Important AAV quality attributes include vector genome titer, capsid purity, residual host-cell DNA, residual plasmid DNA, residual host-cell proteins, endotoxin, sterility-related attributes, genome integrity, empty/full capsid ratio, and functional activity.

PackGene’s analytical services are designed to support characterization of key AAV quality attributes, including titer, purity, safety-related testing, and project-specific assay needs. Available or described methods include qPCR, ddPCR, SDS-PAGE, TEM, mass photometry, mycoplasma or bioburden testing, and other QC assays depending on the service package and development stage.

For research-grade AAV vectors, core quality testing may focus on titer, purity, endotoxin, and basic identity. For preclinical or GMP-oriented programs, broader analytical packages may be needed to support comparability, release testing, stability assessment, and regulatory documentation.

Flexible Customization Options

One of the main advantages of custom AAV services is flexibility. Different research programs may require different combinations of serotype, promoter, transgene, reporter system, regulatory elements, purification method, and quality control assays. For example, a neuroscience project may require a neuron-specific promoter and a CNS-tropic capsid, while a liver-directed study may require hepatocyte-biased expression and high-purity material for systemic administration.

PackGene can support customized AAV development in areas such as:

• Gene overexpression and reporter expression.
• shRNA, miRNA, or gene knockdown studies.
• CRISPR/Cas or genome editing support vectors.
• Tissue-specific or cell-type-specific expression cassette design.
• Disease modeling and mechanism-of-action studies.
• Preclinical proof-of-concept and translational research.
• Serotype and capsid selection for specific tissues or delivery routes.

This flexibility allows researchers to align vector design with experimental objectives rather than adapting experiments to a limited set of standard vectors.

Professional Technical Support

Custom AAV projects often require careful planning before production begins. Factors such as cassette size, ITR integrity, promoter selection, transgene sequence, capsid choice, delivery route, target tissue, dose range, and downstream assay design can all influence project success. Technical support is therefore a critical part of a custom AAV service.

PackGene’s service model includes expert design support to help researchers select appropriate vector configurations and production strategies for their applications. This support can be especially valuable for complex projects involving large transgenes, difficult-to-package constructs, tissue-specific expression, capsid comparison, or translational development requirements.

PackGene’s Commitment to AAV Research and Development

PackGene positions itself as an integrated AAV service provider supporting researchers, biotech companies, and gene therapy developers across different stages of development. By combining custom vector design, scalable AAV production, purification, quality control, and analytical testing, PackGene helps researchers generate fit-for-purpose AAV vectors for both discovery and translational applications.

As AAV technologies continue to advance, the need for reliable, flexible, and well-characterized vector production will only increase. PackGene’s custom AAV services are designed to help researchers move from concept to high-quality AAV material more efficiently, supporting progress in gene delivery research, disease modeling, and next-generation gene therapy development.

Conclusion

Custom AAV services play an essential role in modern biomedical research by enabling precise, application-specific gene delivery. High-quality AAV production requires not only vector packaging, but also thoughtful design, robust purification, appropriate analytical testing, and expert technical support.

Through its integrated AAV service platform, PackGene supports researchers seeking reliable, customizable, and quality-focused AAV solutions. From early experimental design to scalable vector production and characterization, PackGene helps advance AAV-based research and translational gene therapy development.